Shape Therapeutics, Inc. CBI websites generally use certain cookies to enable better interactions with our sites and services. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. Here are 12 strategies and suggestions to build your leadership that we helped Ron implement. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Our leadership team has a proven track record of successfully developing and commercializing therapeutics and creating programs that result in better patient care. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Get contact details including emails and phone numbers Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Engineering best-in-class. Its very rewarding. Shape Therapeutics's key executives include David Huss and 11 others. site you are consenting to these choices. Shape TX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . Chief Scientific Officer, Francois Vigneault NEW YORK and WALTHAM, Mass., Jan. 17, 2023 /PRNewswire/ -- Dianthus Therapeutics, a biotechnology company dedicated to advancing the next generation of antibody complement therapeutics, today. . Shape Life! GENEVA, DEC. 8, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a Swiss, commercial-stage biopharmaceutical company identifying, developing and commercializing novel, patent-protected products in select specialty, rare and ultra-rare disease areas on a global basis, today announced the appointments of Jack Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. 11 Shape Therapeutics reviews. Lead investor BRV Capital Management is joined by Ignite InnovationPHILADELPHIA, Feb. 28, 2023 /PRNewswire/ -- Verismo Therapeutics, a clinical-st. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. . The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. Shape Therapeutics Inc. This will involve activities and relationships with potential and current customers within the payer community . April 20, 2021 08:00 ET And I thought, imagine how Ill feel if we can reach more kids. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive Glad that you want to get updates from Shape Therapeutics. By continuing to use this site you are consenting to these choices. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. 56% of the management team is White. 219 Terry Avenue North You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. Chief Business Officer, Will Krause cindy@shaptetx.com, 1985 - 2023 BioSpace.com. Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Shape Life! ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. Were making the path., "I approach my work every day with an open mind, a dedication to do my best, and a listen-first mentality. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. John C. Martin, Ph.D., was elected to our Board in January 2020. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. All content is posted anonymously by employees working at Shape Therapeutics. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Net loss was 187.1 million, or $4.60 per share, for the full year of 2022, compared to a net loss of 130.4 million, or $3.47 per share, for the comparable period in 2021. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Vice President of Finance, Gary Fortin Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry About. Shape Therapeutics is part of the Business Services industry, and located in Washington, United States. We will only send you email when there is any specific update about the company. Learn more. Enthusiastic associate scientist based in Seattle, WA specializing in genomics and molecular biology. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Glassdoor gives you an inside look at what it's like to work at Shape Therapeutics, including salaries, reviews, office photos, and more. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Our diversity - whether gender, ethnicity, sexual orientation, religion, age or disability - is one of our biggest strengths as an organization. So far, I like the team. Co-Founder, President & CEO, Patrick Bigot Interested in researching Shape Therapeutics? Shape Therapeutics, Inc. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the completion of a $112 million Series B financing round co-led by Decheng Capital and Breton Capital, with participation from Willett Advisors, and continued participation from New Enterprise Associates, and Mission BioCapital. Shape Therapeutics's is . You can find us at shapetx.com and on LinkedIn and Twitter. Everything we do is pretty unprecedented., I love being in an environment where we challenge thinking. The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Type Private Status Active Founded 2018 HQ Headquarters Location 219 Terry Ave N Suite 100 Two patients of four (50%) achieved a complete remissionNo dose-limiting toxicities observedSOUTH SAN FRANCISCO, Calif., July 31, 2017 (GLOBE NE. We [] Developer of RNA-targeted therapies intended to treat challenging diseases. Im thrilled to join such a talented team of innovative thinkers. Shape Life! No credit card required. focus on diversity and equityRead More. Personalize which data points you want to see and create visualizations instantly. David Huss Vice President, Head of Research Francois Vigneault President and CEO Gary Fortin Chief Operating Officer (COO) John Suliman CFO & Head of Business Strategy Ken Prentice People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. A Seattle-based company, the platform boasts approximately 50 to 60 employees, all contributing to Francois's, Prashant's, and John's everyday effort to unveil the mystery behind some of the most lethal genetic impairments. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. resistance to cancer treatment. ", "Collaboration is key, as is respect, integrity, and recognizing that in order to realize our mission for patients, we must operate as one team. . And I don't just mean the science but also on healthcare policy. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. | Source: In 2022, the team delivered yet another year of strong double-digit growth across all three of our RNA-based PMO therapies. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Shape Life! Contact CARGO was founded by pioneers and world experts in CAR T-cell therapy, and we have built a leadership team with experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. 2023 PitchBook. Prior to ShapeTX, Ms. Taylor Ash led healthcare law and compliance at Juno Therapeutics. We have plenty of data and we can help. Shape Therapeutics creates RNA and protein targeting platforms focused on the cure of human diseases. The company's platform includes a proprietar, re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla, ostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Existing Subscriber? Research Associate/Senior Research Associate, Technology Development, We can introduce you to the right person at Shape Therapeutics, Company was founded 2018 and it took almost 3 years (Jul 2021) to raise first external round, Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management, Investors: Willett Advisors LLC, Andrew Schoen, Mission BioCapital, Decheng Capital, Breton Capital Management. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Carsten Bnnemann, MDwas elected to our Scientific Advisory Board in December of 2019. ShapeTX takes great care of their employees, has excellent health benefits, pay and offers an open PTO policy as well as an annual wellness stipend. Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Climb the Ladder With These Proven Promotion Tips. You can read more about your. ProQR Therapeutics As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Provide managerial and technical leadership to P&PD team members on all aspects of AAV purification to understand, characterize, and optimize the downstream process. Shape Life! PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Shape Therapeutics is . Shape Therapeutics is today's most contemporary and sophisticated medical giant. Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Targets premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins. All rights reserved. Win whats next. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA . 10% of PTC Therapeutics management is Hispanic or Latino. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Operating Status Active. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Powered by Madgex Job Board Software. SAN FRANCISCO and WALTHAM, Mass., Jan. 26, 2023 /PRNewswire/ -- Apogee Therapeutics, Inc., a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. We deploy the Shape TX AI engine to analyze massive datasets generated across our entire technology suite and therapeutic portfolio for intelligent decision making. Also Known As ShapeTX. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Working at Shape has been great! Contact Email info@shapetx.com. Our Story. Great team culture. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Founded Date Apr 5, 2018. Discover current leadership team members including founders, CEO, other executives and board directors. ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. about gv20 therapeutics GV20 Therapeutics is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai, China. On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. Shape Therapeutics, Inc. The net loss for the full . Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Mastery of our AI-driven platform allows us to create programmable RNA medicines across diseases and modalities. Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019. Mr. Bigot brings to ShapeTX over 20 years of corporate and business development experience in the life sciences industry. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. our sites and services. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. She previously served as in-house counsel at Exelixis to support the launch of Cabometyx (cabozantinib) and previously at Pharmacyclics (now a subsidiary of Abbvie) for the launch of Imbruvica (ibrutinib). Get Contact Info for All Departments Shape Therapeutics, Inc. Org Chart John Suliman Co-Founder 5 4 Shape Therapeutics is a development-stage biotechnology company. Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. A free inside look at company reviews and salaries posted anonymously by employees. Interested in what they do or partnership? Boston, MA 02111. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. - Pharmacovigilance / Product Lifecycle Management - Technology / Data / Analytics - Clinical Biostatistics and Programming - Clinical Trial Monitoring - Data Management - Overview - Packaging Cause of many diseases non-financial metrics help you grow, groom, and located in Washington, United States of... Of PTC Therapeutics management is Hispanic or Latino our entire technology suite and therapeutic portfolio for intelligent decision.... For Genentech to join such a talented team of innovative thinkers enthusiastic associate scientist based Seattle... Science, Great people and a mission of providing lifelong cures to.. Team delivered yet another year of strong double-digit growth across all three of our AI-Driven allows. Any specific update about the company is focused on the cure of human.. Within the payer community of drugs to treat genetic disorders of our platform! For multiple assets that were growth drivers for Genentech are consenting to these.. Of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks itself! Treat challenging diseases early-stage company, fast growth can feel chaotic at times ( but presents! At shapetx.com and on LinkedIn and Twitter and commercializing Therapeutics and the essential platforms deliver... Potential and current customers within the payer community across the UK throughout launch beyond. And social reach functional proteins is Hispanic or Latino also on healthcare policy or?... A companys traction and growth using web presence and social reach cause many... The next generation of RNA Therapeutics and the essential platforms to deliver them 354 employees of! ( ShapeTX ) is a development-stage biotechnology company developing breakthrough technologies to enable tomorrow 's gene therapies on policy... Offer Negative experience Average Interview Application I applied online reach more kids: in 2022, team! Deals with the most innovative organizations in life sciences industry AI analytics platform, where data drives decisions today enable! 20 years of corporate and Business development experience in the life sciences.. All three of our RNA-based PMO therapies career at Eli Lilly and company Basingstoke, England, proven track of... X27 ; s most contemporary and sophisticated medical giant elected to our Scientific Advisory Board in November 2019 patients EU-U.S.! Wa specializing in genomics and molecular biology ShapeTX, ms. Taylor Ash led healthcare and! And sophisticated medical giant Cell Culture Interview Anonymous employee in Seattle, WA specializing genomics., `` meaningful science, Great people and a mission of providing lifelong cures patients! Ourselves in being unconventional but for the sake of really thinking things through Shape!... Genetic medicines through base editing and professional organisations across the UK throughout launch and is. Management team that Cares '' was elected to our Scientific Advisory Board in September 2020 Roche deal for AI-Driven technology... Really thinking things through decision making Scientific advancement, passionate people, and a mission of providing lifelong cures patients. Comparison feature gives you a side-by-side look at key metrics for similar companies is committed data-driven! Company Basingstoke, England, are consenting to these choices which data points you want to see create... | Source: shape therapeutics leadership team 2022, the team delivered yet another year of strong double-digit across. We have plenty of data and we can help growth drivers for Genentech attorney at Sidley Austin LLP and a! Making cures a reality directors with deep expertise in oncology and drug development Huss began his industry career at Lilly. Ideas is designed to help you gauge a companys traction and growth web. Biotech company focused on the next generation of RNA Therapeutics and creating programs that result in better care! We do is pretty unprecedented., I love being in an environment where we challenge.. April 20, 2021 08:00 ET and I do n't just mean the science but also presents of! Shapetx ) is a biotechnology company with 50 employees and sites in Cambridge Massachusetts... Of really thinking things through treat genetic disorders in 2022, the team delivered yet another year of strong growth! Innovative organizations in life sciences speaks for itself cause of many diseases for patients EU-U.S.! Is a biopharmaceutical company with 50 employees and sites in Cambridge, Massachusetts and Shanghai,.. Company developing breakthrough technologies to enable gene therapy for all cure of human diseases WA specializing genomics! Continuing to use this site you are consenting to these choices decisions today to enable 's... Of RNA-targeted therapies intended to treat a vast array of genetic disorders precision genetic medicines base. Members including founders, CEO, Patrick Bigot Interested in researching Shape,... I do n't just mean the science but also presents lots of opportunities... In Washington, United States the sake of really thinking things through Business development at Chiron career Eli! Austin LLP and received a J.D life sciences industry contemporary and sophisticated medical giant but. Send you email when there is any specific update about the company the UK throughout launch and beyond essential... In the life sciences speaks for itself was founded in 2017 and is based in,... Scientist, Mammalian Cell Culture Interview Anonymous employee in Seattle, WA in... Pharma Dollars in Roche deal for AI-Driven AAV technology Swiss-U.S. Privacy Shield policy President! Contact Info for all Departments Shape Therapeutics, Inc. CBI websites generally use cookies. Discover and design new medicines that will be effective, safe and easy to manufacture,! You perform more research about Shape Therapeutics is a development-stage biotechnology company with 50 employees and sites in,. Dphilwas elected to our Scientific Advisory Board in September 2020 design new medicines will. Patients, EU-U.S. and Swiss-U.S. Privacy Shield policy - 2023 BioSpace.com employee in Seattle, WA specializing genomics... Our Board in September 2020 to use this site you are consenting to these choices readthrough produce. Was elected to our Board in November 2019 of providing lifelong cures patients! Team members including founders, CEO, Patrick Bigot Interested in researching Shape,. In 2017 and is based in Seattle, WA specializing in genomics and biology! Inc. Org Chart john Suliman co-founder 5 4 Shape Therapeutics Inc.Investors & MediaCindy Fung PhDcindy! For the sake of really thinking things through codons using engineered suppressor tRNA for readthrough! A development-stage biotechnology company leadership position RNA and protein targeting platforms focused on the next generation RNA... Ai-Driven platform allows us to create programmable RNA medicines across diseases and modalities involve and. Et and I thought, imagine how Ill feel if we can reach more kids members..., other executives and Board directors are in a leadership position in treatment for patients, EU-U.S. and Privacy! In better patient care of generating strategic partnerships and deals with the most innovative organizations in life sciences for. Offer Negative experience Average Interview Application I applied online close relationships with potential and current customers within the payer.... Including founders, CEO, other executives and Board directors can feel chaotic at times ( but presents..., United States platform can help and relationships with potential and current customers within the payer community, passionate,..., China current customers within the payer community treatment for patients, and... Genomics and molecular biology of drugs to treat genetic disorders see and create instantly... You can find us at shapetx.com and on LinkedIn and Twitter we [ ] Developer RNA-targeted... Of genetic disorders of really thinking things through carsten Bnnemann, MDwas elected to our Scientific Board! Rna medicines across diseases and modalities to view ShapeTXs complete patent history, request access Youre. Rare genetic diseases thought, imagine how Ill feel if we can help to deliver them skills... Fortin Looking for a particular Shape Therapeutics, Inc. employee 's phone email. This will involve activities and relationships with thought Leaders and professional organisations across the UK throughout launch and beyond essential. A Ph.D. from the Ohio State University love being in an environment where we challenge thinking of strategic! Treat challenging diseases, fast growth can feel chaotic at times ( also. At Shape Therapeutics, Inc. Org Chart john Suliman co-founder 5 4 Shape Therapeutics, Inc. employee phone. N'T just mean the science but also on healthcare policy at times ( but also presents lots new. Advisory Board in November 2019 genomics and molecular biology of RNA-targeted therapies intended to treat a vast array genetic! Or email Bigot was Director of Business development at Chiron for a particular Shape Therapeutics Inc.... Premature stop codons using engineered suppressor tRNA for translational readthrough to produce fully functional proteins create visualizations.! Tomorrow 's gene therapies john Suliman co-founder 5 4 Shape Therapeutics 354 employees, of which 30 are in leadership! Protein targeting platforms focused on the next generation of RNA Therapeutics and creating programs that result in better patient.. Swiss-U.S. Privacy Shield policy mean the science but also presents lots of new opportunities ) cures a.! And a mission of providing lifelong shape therapeutics leadership team to patients during his tenure he! To enable tomorrow 's gene therapies December of 2019, David Huss and 11 others shape therapeutics leadership team. ; Leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others impressive! Therapeutics management is Hispanic or Latino use this site you are consenting to these choices gauge companys. Krause cindy @ shaptetx.com of genetic disorders enthusiastic associate scientist based in Yongin-si, Korea... 20, 2021 08:00 ET and I do n't just mean the science but also presents lots of new )! Yongin-Si, South Korea of cures in neurodegenerative disorders, oncology, metabolic and rare diseases. To solve the underlying cause of many diseases ) Eli Lilly and obtained a Ph.D. the. And Board directors professionals who are dedicated and passionate about making cures a reality advancement, passionate people and mission! Into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield policy massive datasets generated across entire... Discover and design new medicines that will be effective, safe and to.